Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in the
older population. Classical hallmarks of early and intermediate AMD are accumulation of …

Age-related macular degeneration (AMD) is a leading cause of severe visual loss among
the elderly. AMD patients are tormented by progressive central blurring/loss of vision and …

Purpose: To evaluate the influence of clinical and multimodal imaging parameters on the
duration of acute central serous chorioretinopathy (CSCR) episodes. Methods: Consecutive …

Age-related macular degeneration (AMD), the leading cause of blindness among the
elderly, is without treatment for early disease. Degenerative retinal pigment epithelial (RPE) …

Photoreceptors, especially cones, which are enriched in the human macula, have high
energy demands, making them vulnerable to metabolic stress. Metabolic dysfunction of …

Increases in the number of cell therapies in the preclinical and clinical phases have
prompted the need for reliable and noninvasive assays to validate transplant function in …

Purpose: Lipofuscin and melanolipofuscin organelles in retinal pigment epithelium (RPE)
cells are signal sources for clinical fundus autofluorescence (AF). To elucidate the …

Age-related macular degeneration (AMD) is the leading cause of visual loss and affects
millions of people worldwide. Dysfunction of the retinal pigment epithelium (RPE) is …

Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss and
dysfunction in the retinal pigment epithelium (RPE) with age is known to contribute to …

The senescence of retinal pigment epithelial (RPE) cells is associated with age-related
macular degeneration (AMD), a leading cause of blindness in the world. HSP90 is a …